The global Patient Monitoring Devices Market was valued at USD 54.3 billion in 2025 and is projected to grow from USD 58.9 billion in 2026 to USD 118.2 billion by 2033, registering a CAGR of 10.5% from 2026 to 2033. North America accounted for the largest revenue share of 34.9% in 2025, driven by advanced healthcare infrastructure, strong adoption of digital health technologies, and...

According to a new report from Intel Market Research, the global AI Healthcare Workflow market was valued at USD 16.8 billion in 2025 and is projected to reach USD 62.5 billion by 2034, exhibiting a CAGR of 31.2% during the forecast period (2026–2034). This growth is driven by the accelerating digitization of health systems, rising demand for operational efficiency, and the expanding...

According to a new report from Intel Market Research, the global Digital Therapeutics Devices market was valued at USD 6.51 billion in 2025 and is projected to grow from USD 7.82 billion in 2026 to USD 35.78 billion by 2034, exhibiting a robust CAGR of 21.0% during the forecast period (2026–2034). This rapid expansion is underpinned by escalating prevalence of chronic illnesses, soaring...

The Global Tracheotomy Tube Market continues to demonstrate consistent expansion, supported by rising critical respiratory care needs and advancements in airway management technologies. Valued at USD 183 million in 2024, the market is projected to grow to USD 241 million by 2031, registering a 4.1% CAGR during the forecast period. The increasing incidence of chronic respiratory disorders,...

 The increasing incidence of chronic respiratory disorders, severe infections, trauma cases, and long-term ventilator dependence is driving the adoption of tracheostomy tubes across hospitals, emergency departments, and homecare settings worldwide. As tracheotomy procedures become more common in intensive care units (ICUs) and emergency settings, demand for safer, flexible, and...

Venous thromboembolism (VTE) remains a major global health concern, encompassing conditions such as deep venous thrombosis and pulmonary embolism. Rising disease prevalence, increasing awareness of thrombotic disorders, and advancements in anticoagulant therapies are contributing to sustained industry expansion across developed and emerging economies. The Venous Thromboembolism Drug Market...